148 related articles for article (PubMed ID: 32386904)
1. Transcutaneous immunization with a highly active form of XCL1 as a vaccine adjuvant using a hydrophilic gel patch elicits long-term CD8
Kamei M; Matsuo K; Imanishi H; Hara Y; Quen YS; Kamiyama F; Oiso N; Kawada A; Okada N; Nakayama T
J Pharmacol Sci; 2020 Jul; 143(3):182-187. PubMed ID: 32386904
[TBL] [Abstract][Full Text] [Related]
2. A Highly Active Form of XCL1/Lymphotactin Functions as an Effective Adjuvant to Recruit Cross-Presenting Dendritic Cells for Induction of Effector and Memory CD8
Matsuo K; Kitahata K; Kawabata F; Kamei M; Hara Y; Takamura S; Oiso N; Kawada A; Yoshie O; Nakayama T
Front Immunol; 2018; 9():2775. PubMed ID: 30542351
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral delivery of a highly active form of XCL1 enhances antitumor CTL responses through recruitment of CXCL9-expressing conventional type-1 dendritic cells.
Kamei M; Matsuo K; Yoshida Y; Shimada K; Otsuki M; Fujimoto N; Ishibashi M; Quan YS; Kamiyama F; Hara Y; Takamura S; Nakayama T
Int J Cancer; 2024 Jun; 154(12):2176-2188. PubMed ID: 38346928
[TBL] [Abstract][Full Text] [Related]
4.
Chen K; Wu Z; Zhao H; Wang Y; Ge Y; Wang D; Li Z; An C; Liu Y; Wang F; Bi X; Wang H; Cai J; Ma C; Qu C
Cancer Immunol Res; 2020 Jan; 8(1):81-93. PubMed ID: 31666238
[TBL] [Abstract][Full Text] [Related]
5. The administration route is decisive for the ability of the vaccine adjuvant CAF09 to induce antigen-specific CD8(+) T-cell responses: The immunological consequences of the biodistribution profile.
Schmidt ST; Khadke S; Korsholm KS; Perrie Y; Rades T; Andersen P; Foged C; Christensen D
J Control Release; 2016 Oct; 239():107-17. PubMed ID: 27574990
[TBL] [Abstract][Full Text] [Related]
6. The invariant natural killer T cell-mediated chemokine X-C motif chemokine ligand 1-X-C motif chemokine receptor 1 axis promotes allergic airway hyperresponsiveness by recruiting CD103
Woo YD; Koh J; Kang HR; Kim HY; Chung DH
J Allergy Clin Immunol; 2018 Dec; 142(6):1781-1792.e12. PubMed ID: 29474842
[TBL] [Abstract][Full Text] [Related]
7. Combination of Synthetic Long Peptides and XCL1 Fusion Proteins Results in Superior Tumor Control.
Botelho NK; Tschumi BO; Hubbell JA; Swartz MA; Donda A; Romero P
Front Immunol; 2019; 10():294. PubMed ID: 30863405
[TBL] [Abstract][Full Text] [Related]
8. ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells.
Duewell P; Kisser U; Heckelsmiller K; Hoves S; Stoitzner P; Koernig S; Morelli AB; Clausen BE; Dauer M; Eigler A; Anz D; Bourquin C; Maraskovsky E; Endres S; Schnurr M
J Immunol; 2011 Jul; 187(1):55-63. PubMed ID: 21613613
[TBL] [Abstract][Full Text] [Related]
9. Laser-assisted intradermal delivery of adjuvant-free vaccines targeting XCR1+ dendritic cells induces potent antitumoral responses.
Terhorst D; Fossum E; Baranska A; Tamoutounour S; Malosse C; Garbani M; Braun R; Lechat E; Crameri R; Bogen B; Henri S; Malissen B
J Immunol; 2015 Jun; 194(12):5895-902. PubMed ID: 25941327
[TBL] [Abstract][Full Text] [Related]
10. Comparison of two different PEGylation strategies for the liposomal adjuvant CAF09: Towards induction of CTL responses upon subcutaneous vaccine administration.
Schmidt ST; Olsen CL; Franzyk H; Wørzner K; Korsholm KS; Rades T; Andersen P; Foged C; Christensen D
Eur J Pharm Biopharm; 2019 Jul; 140():29-39. PubMed ID: 31055066
[TBL] [Abstract][Full Text] [Related]
11. [In Vivo Antigen Delivery to Dendritic Cells-A Novel Peptide Vaccine for Cancer Therapy].
Mizumoto Y; Katsuda M; Miyazawa M; Kitahata Y; Miyamoto A; Nakamori M; Ojima T; Matsuda K; Hemmi H; Tamada K; Kaisho T; Yamaue H
Gan To Kagaku Ryoho; 2018 Oct; 45(10):1469-1471. PubMed ID: 30382048
[TBL] [Abstract][Full Text] [Related]
12. Effective Respiratory CD8 T-Cell Immunity to Influenza Virus Induced by Intranasal Carbomer-Lecithin-Adjuvanted Non-replicating Vaccines.
Gasper DJ; Neldner B; Plisch EH; Rustom H; Carrow E; Imai H; Kawaoka Y; Suresh M
PLoS Pathog; 2016 Dec; 12(12):e1006064. PubMed ID: 27997610
[TBL] [Abstract][Full Text] [Related]
13. Directed antigen targeting in vivo identifies a role for CD103+ dendritic cells in both tolerogenic and immunogenic T-cell responses.
Semmrich M; Plantinga M; Svensson-Frej M; Uronen-Hansson H; Gustafsson T; Mowat AM; Yrlid U; Lambrecht BN; Agace WW
Mucosal Immunol; 2012 Mar; 5(2):150-60. PubMed ID: 22166938
[TBL] [Abstract][Full Text] [Related]
14. Co-immunization with L-Myc enhances CD8
Chai D; Zhang Z; Jiang N; Ding J; Qiu D; Shi SY; Wang G; Fang L; Li H; Tian H; Yang J; Zhang Q; Zheng J
Cancer Sci; 2021 Sep; 112(9):3469-3483. PubMed ID: 34157192
[TBL] [Abstract][Full Text] [Related]
15. Intranasal delivery of a cDC1 targeted influenza vaccine with poly(I:C) enhances T cell responses and protects against influenza infection.
Lysén A; Gudjonsson A; Tesfaye DY; Bobic S; Bern M; Bogen B; Fossum E
Scand J Immunol; 2022 Mar; 95(3):e13128. PubMed ID: 34923667
[TBL] [Abstract][Full Text] [Related]
16. Anticancer effects of chemokine-directed antigen delivery to a cross-presenting dendritic cell subset with immune checkpoint blockade.
Mizumoto Y; Hemmi H; Katsuda M; Miyazawa M; Kitahata Y; Miyamoto A; Nakamori M; Ojima T; Matsuda K; Nakamura M; Hayata K; Fukuda-Ohta Y; Sugiyama M; Ohta T; Orimo T; Okura S; Sasaki I; Tamada K; Yamaue H; Kaisho T
Br J Cancer; 2020 Apr; 122(8):1185-1193. PubMed ID: 32066911
[TBL] [Abstract][Full Text] [Related]
17. Intradermal injections of polyarginine-containing immunogenic antigens preferentially elicit Tc1 and Th1 activation and antitumour immunity.
Mitsui H; Okamoto T; Kanzaki M; Inozume T; Shibagaki N; Shimada S
Br J Dermatol; 2010 Jan; 162(1):29-41. PubMed ID: 19863514
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cell-mediated induction of mucosal cytotoxic responses following intravaginal immunization with the nontoxic B subunit of cholera toxin.
Luci C; Hervouet C; Rousseau D; Holmgren J; Czerkinsky C; Anjuère F
J Immunol; 2006 Mar; 176(5):2749-57. PubMed ID: 16493030
[TBL] [Abstract][Full Text] [Related]
19. Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory.
Hao S; Yuan J; Xiang J
J Leukoc Biol; 2007 Oct; 82(4):829-38. PubMed ID: 17626150
[TBL] [Abstract][Full Text] [Related]
20. Imaging of the cross-presenting dendritic cell subsets in the skin-draining lymph node.
Kitano M; Yamazaki C; Takumi A; Ikeno T; Hemmi H; Takahashi N; Shimizu K; Fraser SE; Hoshino K; Kaisho T; Okada T
Proc Natl Acad Sci U S A; 2016 Jan; 113(4):1044-9. PubMed ID: 26755602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
